The shoulder system received FDA clearance in March, and a commercial launch is planned for later this year, according to the May 5 news release. The single-tray arthroplasty system maximizes efficiency and bone preservation, Catalyst said.
“These first surgeries with our Archer R1 reverse system went well, and we’re excited by the feedback we’re getting from the initial surgeon users,” Catalyst chair and CEO Brian Hutchinson said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.